https://www.selleckchem.com/pr....oducts/3-methyladeni
The risk of colorectal cancer (CRC) in patients with inflammatory bowel diseases (IBD) is higher compared to the general population and it is related to the type, severity, duration, and extension of the disease. This review aims to highlight current evidence from the literature supporting the role of endoscopic surveillance of CRC in patients with IBD. Even in the absence of randomized controlled trials (RCTs), evidence from the literature supports the effectiveness of endoscopic surveillance in reducing IBD-related CRC inciden
Like
Comment
Share
